Send the following on WhatsApp
Continue to ChatPioglitazone/Exenatide/SGLT-2 inhibitor combination therapy versus insulin therapy in patients with poorly controlled type 2 diabetes - https://dergipark.org.tr/tr/pub/acmj/issue/83450/1415215
Pioglitazone/Exenatide/SGLT-2 inhibitor combination therapy versus insulin therapy in patients with poorly controlled type 2 diabetes - https://dergipark.org.tr/tr/pub/acmj/issue/83450/1415215